Advertisement

Topics

EpiPen 'Failures': More Bad Headlines For Mylan – And Reminder Of FDA's Own Risks

06:59 EST 9 Nov 2017 | SCRIP

Latest headlines about EpiPen cite deaths associated with product 'failures.' The attention is probably unfair, given the source (US FDA...

      

Related Stories

 

Original Article: EpiPen 'Failures': More Bad Headlines For Mylan – And Reminder Of FDA's Own Risks

NEXT ARTICLE

More From BioPortfolio on "EpiPen 'Failures': More Bad Headlines For Mylan – And Reminder Of FDA's Own Risks"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...